| |
| |
|
| Insider
Information: |
Hoffman Robert |
| Relationship: |
President, CEO, and CF... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
142,188 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,001,958 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,188 |
|
|
| Total
Value |
$6,001,958 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -77.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arena Pharmaceuticals Inc |
ARNA |
SVP, Finance and CFO |
2014-12-15 |
58,074 |
2003-06-30 |
0 |
Premium* |
|
|
CombiMatrix Corp |
CBMX |
Director |
2017-11-14 |
0 |
2013-12-20 |
0 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
|
2017-04-02 |
4,438 |
2014-12-16 |
0 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
Director |
2015-03-17 |
9,494 |
|
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
CFO & SVP, Finance |
2018-07-02 |
1,280 |
2017-10-31 |
0 |
Premium* |
|
|
Kintara Therapeutics, Inc |
KTRA |
President, CEO, and CF... |
2023-06-01 |
68,902 |
2022-02-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KTRA |
Kintara Therapeutics, Inc |
President, CEO, and CFO |
• • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
59,800 |
68,902 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
President and CEO |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
400,145 |
455,145 |
0 |
- |
|
| KTRA |
Kintara Therapeutics, Inc |
President and CEO |
• • – |
2022-02-15 |
4 |
B |
$0.47 |
$25,795 |
D/D |
55,000 |
55,000 |
2.81 |
% |
|
| HRTX |
Heron Therapeutics Inc |
CFO & SVP, Finance |
• – – |
2018-07-02 |
4 |
AS |
$38.15 |
$1,145,230 |
D/D |
(30,000) |
1,280 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
CFO & SVP, Finance |
• – – |
2018-07-02 |
4 |
OE |
$15.30 |
$459,000 |
D/D |
30,000 |
31,280 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
CFO & SVP, Finance |
• – – |
2018-04-30 |
4 |
A |
$13.22 |
$9,834 |
D/D |
744 |
1,280 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2017-11-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,001) |
6,618 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2017-11-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,618) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
CFO & SVP, Finance |
• – – |
2017-10-31 |
4 |
A |
$13.05 |
$6,993 |
D/D |
536 |
536 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
|
– • – |
2017-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,543 |
4,438 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2016-05-10 |
4 |
B |
$3.19 |
$15,963 |
D/D |
5,000 |
7,409 |
2.39 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
|
– • – |
2016-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,417 |
21,417 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
Director |
– • – |
2015-03-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,494 |
|
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2015-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,528 |
54,295 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
Director |
– • – |
2014-12-16 |
4 |
B |
$2.40 |
$24,000 |
D/D |
10,000 |
21,116 |
2.39 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2014-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
58,074 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,495 |
41,767 |
0 |
- |
|
| CBMX |
CombiMatrix Corp |
Director |
– • – |
2013-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
24,272 |
24,272 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2013-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
40,820 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2013-04-01 |
4 |
AS |
$8.21 |
$585,126 |
D/D |
(71,250) |
19,570 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2013-04-01 |
4 |
OE |
$1.81 |
$128,963 |
D/D |
71,250 |
90,820 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,382 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2012-10-01 |
4 |
AS |
$8.32 |
$415,980 |
D/D |
(50,000) |
3,382 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2012-10-01 |
4 |
OE |
$1.48 |
$74,000 |
D/D |
50,000 |
53,382 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP, Finance and CFO |
• – – |
2012-07-05 |
4 |
S |
$11.00 |
$110,000 |
D/D |
(10,000) |
2,763 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
